SEC Form 4 · accession 0001179110-15-001205
VioQuest Pharmaceuticals, Inc. · VOQP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark D Dacko
Officer — CFO and Secretary · Director
Period of report
Jan 16, 2015
Accepted (ET)
Jan 23, 2015 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000745788
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options(right to buy) | $0.05 | Jan 16, 2015 | A | 500,000 | A | Jan 16, 2015 | Jan 16, 2025 | Common Stock | 500,000 | 500,000 | D |
| Stock Options (right to buy) | $0.02 | holding | — | — | — | May 31, 2013 | May 31, 2023 | Common Stock | 500,000 | 500,000 | D |